ARCHIVES

NCI Proposal Would Give Drug Sponsors Commercial Rights To Biomarker Inventions

This article is from The Cancer Letter archive.

Vol. 35 No. 38 | October 16, 2009

Download PDF Visit The Full Archive

Related Articles

CTEP Director Friedman Adds To Article On Minority Initiative

March 23, 1990

Family History of BRCA Mutation Does Not Equal Increased Risk

October 28, 2011

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

NCAB Committee Close To Definition Of QRA

February 11, 1983